DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Ancestim
Ancestim
Ontario Drug Benefit Formulary Edition 43
Tanibirumab (CUI C3490677) Add to Cart
Pharmaceutical Appendix to the Harmonized Tariff Schedule
WO 2016/174183 Al 3 November 2016 (03.11.2016) P O P C T
STEMGEN® (Ancestim) Product Information Page 1 of 12
WO 2015/195228 Al 23 December 2015 (23.12.2015) P O P C T
Ontario College of Pharmacists Council Meeting Agenda Thursday, August 22, 2019 – 10:00 A.M. Council Chambers, 483 Huron
(12) United States Patent (10) Patent No.: US 8,957,053 B2 Geri Et Al
BMJ Open Is Committed to Open Peer Review. As Part of This Commitment We Make the Peer Review History of Every Article We Publish Publicly Available
Lääkeaineiden Yleisnimet (INN-Nimet) 21.6.2021
Anatomical Classification Guidelines V2021 EPHMRA ANATOMICAL CLASSIFICATION GUIDELINES 2021
Anatomical Classification Guidelines V2020 EPHMRA ANATOMICAL
Antithrombin III(BAN, Rinn)
WO 2016/091891 Al O
Stembook 2018.Pdf
Section B Changed Classes/Guidelines Final Version Date of Issue
Recommendations for the Use of White Blood Cell Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update
International Nonproprietary Names (Inn) for Biological and Biotechnological Substances
Top View
(INN) for Biological and Biotechnological Substances
Mobilization Failure in Hematopoietic Stem Cell Transplantation
Hematopoietic Progenitor Cell Mobilization for Autologous Transplantation
Peripheral Blood Progenitor Cells Mobilization in Patients with Multiple Myeloma
Canadian Supportive Care Recommendations for the Management of Neutropenia in Patients with Cancer
6.6.2018 a Abacavir Abacavirum Abakaviiri Abagovomab
Anatomical Classification Guidelines V2018 EPHMRA ANATOMICAL
Systematic Review of Randomized Controlled Trials of Hematopoietic Stem Cell Mobilization Strategies for Autologous Transplantat
Antiproliferative and Carbonic Anhydrase II Inhibitory
Human Granulocyte-Colony Stimulating Factor (G-CSF)/Stem Cell Factor (SCF) Fusion Proteins: Design, Characterization and Activity
How I Treat Patients Who Mobilize Hematopoietic Stem Cells Poorly
Changes Highlighted Final Version Date of Issue
ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
Changes Highlighted Final Version Date of Issue
WO 2012/136776 Al 11 October 2012 (11.10.2012) P O P C T
Pdf/2009-10/Firmagon - Ct-6725.Pdf 58
BMJ Open Is Committed to Open Peer Review. As Part of This Commitment We Make the Peer Review History of Every Article We Publish Publicly Available
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Filgrastim And&Sol
Clinicalkey Drug Monographs
ATC Vet 2021 Atccode Atcdescription Atcdescriptionsi QA ALIMENTARY TRACT and METABOLISM ZDRAVILA ZA BOLEZNI PREBAVIL in PRESNOVE
Improving Stem Cell Mobilization Strategies: Future Directions
Ontario Drug Benefit Formulary Edition 42
Prescription Drug List Products for Human
(INN) for Biological and Biotechnological Substances
Biovitrum Full Year Report 2008
(12) Patent Application Publication (10) Pub. No.: US 2014/0242075A1 Parren Et Al
(INN-Nimet) 8.12.2020
CNPBC Scope of Practice for Naturopathic Physicians: Standards, Limits and Conditions for Prescribing, Dispensing and Compounding Drugs
Concept ID Name Class 1319998 Acebutolol Adrenergics 1154343
Product Monograph Stemgen®
( 12 ) United States Patent
Progenitor Cell Mobilisation Optimising Parameters for Peripheral Blood Leukapheresis After R
Novel Agents and Approaches for Stem Cell Mobilization in Normal Donors and Patients
A Randomized Phase II Pilot Study of Mobilization and Engraftment
Comprehensive Analysis of Mutation-Based and Expressed Genes-Based Pathways in Head and Neck Squamous Cell Carcinoma
2000 Annual Report Dramatically Improving People’S Lives
WO 2014/108198 Al 17 July 2014 (17.07.2014) P O P C T
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
(12) Patent Application Publication (10) Pub. No.: US 2016/0159877 A1 Retallack Et Al